Magnus Olafsson Corfitzen
Chief Executive Officer chez ASCELIA PHARMA AB
Fortune : 275 323 $ au 31/03/2024
Profil
Mr. Magnus Olafsson Corfitzen is a Chief Executive Officer at Ascelia Pharma AB.
He is on the Board of Directors at Ascelia Incentive AB and Inventive AB.
Mr. Corfitzen was previously employed as an Investment Director by Sunstone Capital A/S, a Chief Executive Officer by CMC Contrast AB, an Investment Director by Danmarks Eksport- og Investeringsfond, a Portfolio Manager by Danske Bank A/S (Investment Management), a Portfolio Manager by Danske Capital AB, a Chairman by FBC Device ApS, a Principal by McKinsey & Co., Inc., and a Chief Executive Officer by Oncoral Pharma ApS.
He also served on the board at Vivostat A/S, Aro Medical ApS, DentoFit A/S, Nordic Vaccine A/S and Opsona Therapeutics Ltd.
He received his graduate degree from the University of Aarhus.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ASCELIA PHARMA AB
0,95% | 17/07/2023 | 319 645 ( 0,95% ) | 275 323 $ | 31/03/2024 |
Postes actifs de Magnus Olafsson Corfitzen
| Sociétés | Poste | Début |
|---|---|---|
| ASCELIA PHARMA AB | Chief Executive Officer | 01/01/2014 |
| Inventive AB | Director/Board Member | - |
| Ascelia Incentive AB | Director/Board Member | - |
Anciens postes connus de Magnus Olafsson Corfitzen
| Sociétés | Poste | Fin |
|---|---|---|
Sunstone Capital A/S
 Sunstone Capital A/S Investment ManagersFinance Sunstone Capital A/S (Sunstone) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2007 by Peter Benson, Sten Verland, and Søren Lemonius, and invests on behalf of a group of institutional investors. | Director of Investments | 30/06/2014 |
DentoFit A/S
 DentoFit A/S Medical SpecialtiesHealth Technology DentoFit A/S develops non-shrinking composite resin material for dental plastic fillings. Its material is used as filler for dental restorative therapy. The company was founded by Per Bækgård in 2004 and is headquartered in Roskilde, Denmark. | Director/Board Member | 27/01/2014 |
CMC Contrast AB
 CMC Contrast AB Pharmaceuticals: MajorHealth Technology CMC Contrast AB develops magnetic resonance contrast agents for patients suffering with tumors. Its product CMC 001 is a Manganese containing orally administered magnetic resonance imaging (MRI) contrast medium for enhancement of the liver, bile ducts and gastrointestinal tract. The company was founded by Henrik S. Thomsen in 2000 and is headquartered in Malmo, Sweden. | Chief Executive Officer | - |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Danske Bank A/S (Investment Management)
 Danske Bank A/S (Investment Management) Investment ManagersFinance Danske Bank A/S (Investment Management) (Danske Bank-IM) is the investment management division of Danske Bank A/S (CO: DANSKE, ADR: DNKEY) in Denmark. The firm was founded in 1871 and is headquartered in Kongens Lyngby. Danske Bank-IM manages Nordic, European and Eastern European assets for institutional clients in the life and pensions sector, foundations, municipalities, corporate clients, mutual funds and retail investors. They outsource investment areas outside of their core expertise to external managers. | Corporate Officer/Principal | - |
Formation de Magnus Olafsson Corfitzen
| University of Aarhus | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ASCELIA PHARMA AB | Health Technology |
| Entreprise privées | 15 |
|---|---|
CMC Contrast AB
CMC Contrast AB Pharmaceuticals: MajorHealth Technology CMC Contrast AB develops magnetic resonance contrast agents for patients suffering with tumors. Its product CMC 001 is a Manganese containing orally administered magnetic resonance imaging (MRI) contrast medium for enhancement of the liver, bile ducts and gastrointestinal tract. The company was founded by Henrik S. Thomsen in 2000 and is headquartered in Malmo, Sweden. | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Danske Bank A/S (Investment Management)
Danske Bank A/S (Investment Management) Investment ManagersFinance Danske Bank A/S (Investment Management) (Danske Bank-IM) is the investment management division of Danske Bank A/S (CO: DANSKE, ADR: DNKEY) in Denmark. The firm was founded in 1871 and is headquartered in Kongens Lyngby. Danske Bank-IM manages Nordic, European and Eastern European assets for institutional clients in the life and pensions sector, foundations, municipalities, corporate clients, mutual funds and retail investors. They outsource investment areas outside of their core expertise to external managers. | Finance |
Danske Capital AB
 Danske Capital AB Investment ManagersFinance Danske Capital AB (Danske Sweden) is the Swedish asset management subsidiary of DDB Invest AB, itself a subsidiary of Copenhagen-based Danske Bank A/S (CO: DANSKE; ADR: DNKEY) in Denmark. Located in Stockholm, the firm manages equity, fixed-income, and multi-asset class portfolios in sub-funds for both private and institutional investors. Danske Bank Group is a signatory to the UN Principles for Responsible Investment and strives to conduct business on the basis of customer needs in a profitable and sustainable manner. | Finance |
Danmarks Eksport- og Investeringsfond
 Danmarks Eksport- og Investeringsfond Investment ManagersFinance Danmarks Eksport- og Investeringsfond (EIFO) is a venture capital subsidiary of Government of Denmark and founded in 1992. The firm is headquartered in Hellerup, Denmark. | Finance |
Vivostat A/S
 Vivostat A/S Medical SpecialtiesHealth Technology Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark. | Health Technology |
Sunstone Capital A/S
Sunstone Capital A/S Investment ManagersFinance Sunstone Capital A/S (Sunstone) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2007 by Peter Benson, Sten Verland, and Søren Lemonius, and invests on behalf of a group of institutional investors. | Finance |
DentoFit A/S
DentoFit A/S Medical SpecialtiesHealth Technology DentoFit A/S develops non-shrinking composite resin material for dental plastic fillings. Its material is used as filler for dental restorative therapy. The company was founded by Per Bækgård in 2004 and is headquartered in Roskilde, Denmark. | Health Technology |
Nordic Vaccine A/S
 Nordic Vaccine A/S Pharmaceuticals: MajorHealth Technology Nordic Vaccine A/S engages in the development and commercialization of vaccines for prophylactic and therapeutic use. It offers Posintro that combines delivery and immunological properties for the development of prophylactic and therapeutic vaccines. The firm also provides needle free delivery systems, including TransVac, a novel patch system for pain-free, non-invasive, and transdermal delivery of vaccines. The company was founded in 2001 and is headquartered in Copenhagen, Denmark. | Health Technology |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Health Technology |
FBC Device ApS
 FBC Device ApS Medical SpecialtiesHealth Technology FBC Device ApS provides spinal implants for the treatment of degenerative disc disease. Its products include Statur-L. The firm develops and manufactures healthcare equipment that helps in the placement of spine in correct position after an implant surgery. The company was founded by Finn Bjarke Christensen in 2005 and is headquartered in Risskov, Denmark. | Health Technology |
Aro Medical ApS
 Aro Medical ApS Medical SpecialtiesHealth Technology Aro Medical ApS provides novel implant for improving outcomes of discectomy surgery in patients with spine herniaion. The company was founded by Bruce Harshaw Robie on July 12, 2012 and is headquartered in Aarhus, Denmark. | Health Technology |
Oncoral Pharma ApS
 Oncoral Pharma ApS Pharmaceuticals: MajorHealth Technology Oncoral Pharma ApS provides pharmaceuticals for the treatment of colon and rectal cancer. The company was founded by Bent Højgaard, Peter Gudmund Nielsen and Ann Vivian Fullerton in 21013 and is headquartered in Ballerup, Denmark. | Health Technology |
| Ascelia Incentive AB | |
| Inventive AB |
